Penny Stocks To Research – May 31st

Hub Cyber Security, Inspira Technologies OXY B.H.N., Inspira Technologies OXY B.H.N., Sidus Space, DevvStream, PainReform, and Clearmind Medicine are the seven Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are shares of very low-priced companies, typically trading for a few dollars or less per share, and are often issued by small, lightly regulated firms. They are considered highly speculative investments because they can be extremely volatile, have low trading volume, and carry a greater risk of loss than more established stocks. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

Hub Cyber Security (HUBC)

HUB Cyber Security Ltd. provides cyber security solutions in Israel and internationally. The company offers HUB Secure File Vault, a super charged managed file transfer backed by dedicated hardware driven security, which creates a secure enclave to protect the organization's data driven workflows; HUB Guard, a recurring security assessment, continuous network, and infrastructure monitoring and analysis, and planned incident response; D.Storm, a powerful SaaS DDoS simulation platform; RAM Commander, a software tool for reliability prediction and analysis, reliability block diagram, Markov chains analysis, maintainability prediction, spares optimization, FMEA/FMECA, testability, fault tree analysis, event tree analysis, and safety assessment; and Safety Commander designs to evaluate the safety of highly integrated systems in a model-based design environment.

Inspira Technologies OXY B.H.N. (IINN)

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.

Inspira Technologies OXY B.H.N. (QTEX)

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.

Sidus Space (SIDU)

Sidus Space, Inc., a space-as-a-service company, engages in the design, manufacture, launch, and data collection of commercial satellite worldwide. Its space services include satellite/space hardware manufacturing; Low Earth Orbit (LEO) launch and deployment services; and space-based geospatial intel, imagery, and data analytics.

DevvStream (DEVS)

DevvStream Holdings Inc. is a carbon credit project co-development and generation firm specializing in technology-based solutions. DevvStream Holdings Inc., formerly known as Focus Impact Acquisition Corp., is based in NEW YORK.

PainReform (PRFX)

PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations.

Clearmind Medicine (CMND)

Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.